What is CCUS? Everything You Need To Know With Dr. Kelly Bolton image

What is CCUS? Everything You Need To Know With Dr. Kelly Bolton

Posted on: Nov 30, 2023
Play Episode
Also available on
Description

What is CCUS? What does progression from CCUS to MDS or AML look like? What is the PIMM study? Learn everything you need to know about CCUS from Dr. Kelly Bolton, CCUS researcher and specialist.

Overview

On this episode of HealthTree Podcast for MDS, we are joined by Dr. Kelly Bolton, physician-scientist from Washington University in St. Louis Missouri. Dr. Bolton gives us, essentially a crash course on CCUS. She covers questions like, "what is CCUS?", "who should treat CCUS?", "what treatment options exist for CCUS?" and "what does progression in CCUS look like?". She ends by talking to us about her exciting PIMM trial in CCUS and how she believes studying CCUS can potentially help prevent patients from progressing into MDS or AML.

Listen to the episode to hear her answers to these questions and many more!

On this episode
Healthtree contact Mary Arnett

Mary Arnett

Volunteer and Community Outreach Manager, HealthTree Foundation

Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Healthtree contact Kelly Bolton, MD

Kelly Bolton, MD

Kelly Bolton is a physician-scientist at Washington University in St Louis. She is currently an assistant professor in the Section of Stem Cell Biology Division, Division of Oncology. Her research group focuses on clonal hematopoiesis and inherited predisposition to cancer. Originally from Los Angeles, she completed her undergraduate studies at Cornell University. She completed medical school at the UCLA School of Medicine and a PhD in Genetic Epidemiology through Cambridge University. She went on to complete her residency in internal medicine and Cornell University and a fellowship in medical oncology at MSKCC. She receives grant support from the National Cancer Institute, the EvansMDS foundation and the Damon Runyon Cancer Research Foundation.